NCT07090785View on ClinicalTrials.gov

A Study of LY4088044 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions

Healthy

Interventions

DRUG

LY4088044

Administered IV

DRUG

LY4088044

Administered SC

DRUG

Placebo

Administered IV

DRUG

Placebo

Administered SC

Trial Locations (3)

78209

NOT_YET_RECRUITING

ICON Early Phase Services, San Antonio

84124

RECRUITING

ICON, Salt Lake City

90720

NOT_YET_RECRUITING

Collaborative Neuroscience Network - CNS, Los Alamitos

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY